
A new injectable therapy harnesses “dancing molecules” to reverse paralysis and repair tissue after severe spinal cord injuries, allowing animal subjects to regain the ability to walk.

Fatty acid uptake produces an epigenetic modification that is required for cancer metastasis, according to a study published in Nature.

The damaging effects of toxic proteins created in one inherited form of amyotrophic lateral sclerosis (ALS) are mediated by an enzyme called SPOP.

A new Northwestern Medicine study published in Nature explains why dopamine neurons are lost in Parkinson’s disease, and demonstrated that a gene therapy targeting the brain’s substantia nigra can substantially boost the benefits of levodopa, an important medication for treating the disease.

Human cells use a protein named TBC1D5 to “trap and kill” influenza A viruses inside host cells, but the virus encodes its own protein to disable this defense.

A newly discovered cause of balding in aging male mice could reveal a cause of hair loss in men and women as well, reports a study from Northwestern Medicine scientists.

TG2, an enzyme known to help cancers spread more quickly, also plays a role in regulating T-cells — opening the door to dual inhibition, according to a recent Northwestern Medicine study.

The underexpression of a specific metabolic enzyme is a common and adverse epigenetic modulating feature in clear cell renal cell carcinoma, which accounts for 80 percent of all kidney cancers, according to a recent study.

T-cells respond to buildup of alpha-synuclein with a harmful auto-immune response, according to a Northwestern Medicine study published in Science.

A machine learning model can identify patients at risk of a rare cardiomyopathy, according to a recent study.
Notifications